Metzger Zvi, Klein Hagay, Klein Abraham, Tagger Michael
Alpha Omega Research Laboratories, The Goldshleger School of Dental Medicine, Tel Aviv University, Israel.
J Endod. 2002 Sep;28(9):643-5. doi: 10.1097/00004770-200209000-00004.
Bone resorption is one of the hallmarks of inflammatory periapical lesions and is mediated by cytokines. Recent insights into the immunobiology of these lesions indicate that pharmacological modulation of their bone resorbing activity may be possible. Periapical lesions were induced in rats by occlusal exposure of the pulps of their lower first molars. The size of the resulting lesions was followed-up and evaluated by image analysis of their radiographs. The lesions increased with time, and the average area of their radiographic images reached 2.18 (+/- 0.33) mm2 by day 21. Systemic dexamethasone treatment (0.5 mg/kg, every third day) inhibited the growth of the periapical lesions, which reached an average area of 1.63 (+/- 0.30) (p < 0.01). These results support the hypothesis that bone resorption in periapical inflammatory lesions may be pharmacologically down regulated.
骨吸收是炎症性根尖周病变的特征之一,且由细胞因子介导。对这些病变免疫生物学的最新见解表明,对其骨吸收活性进行药物调节或许是可行的。通过暴露大鼠下颌第一磨牙的牙髓诱导根尖周病变。通过对其X光片进行图像分析来跟踪并评估所形成病变的大小。病变随时间增加,到第21天时其X光图像的平均面积达到2.18(±0.33)平方毫米。全身应用地塞米松治疗(0.5毫克/千克,每三天一次)抑制了根尖周病变的生长,其平均面积达到1.63(±0.30)(p<0.01)。这些结果支持以下假设:根尖周炎症性病变中的骨吸收可通过药物下调。